Starling Oncology, Inc. Non Peo Neo Avg Total Comp Amt
Starling Oncology, Inc. (DFPH) reported Non Peo Neo Avg Total Comp Amt of $755.02 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-30.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-30
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $755.02K DEF 14A · filed 2026-04-30 |
| 2024-12-31 | $522.37K DEF 14A · filed 2026-04-30 |